| Use a gentle approach for refractory myeloma patients |
| DE Bergsagel |
|
JCO May 1 1988: 757–758.
[PDF]
|
 |
| Questions about clinical trials in hypercalcemia |
| RP Warrell, Jr |
|
JCO May 1 1988: 759–761.
[PDF]
|
|
|
Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP |
| |
D Thiebaud, P Jaeger, AF Jacquet, and P Burckhardt |
| |
JCO May 1 1988: 762–768.
[Abstract]
[PDF]
|
|
|
An update of two randomized trials in previously untreated multiple myeloma comparing melphalan and prednisone versus three- and five-drug combinations: an Argentine Group for the Treatment of Acute Leukemia Study |
| |
S Pavlovsky, C Corrado, MT Santarelli, J Saslavsky, F Cavagnaro, M Palau, M de Tezanos Pinto, A Huberman, and JM Lein |
| |
JCO May 1 1988: 769–775.
[Abstract]
[PDF]
|
|
|
Testicular lymphoma: improved outcome with early brief chemotherapy |
| |
JM Connors, P Klimo, N Voss, RN Fairey, and S Jackson |
| |
JCO May 1 1988: 776–781.
[Abstract]
[PDF]
|
|
|
Squamous cell carcinoma antigen as a marker for squamous cell carcinoma of the anal canal |
| |
NJ Petrelli, N Shaw, A Bhargava, J Daufeldt, L Herrera, JP Stulc, B Sischy, and A Mittelman |
| |
JCO May 1 1988: 782–785.
[Abstract]
[PDF]
|
|
|
Comparison of criteria for assigning germ cell tumor patients to "good risk" and "poor risk" studies |
| |
D Bajorin, A Katz, E Chan, N Geller, N Vogelzang, and GJ Bosl |
| |
JCO May 1 1988: 786–792.
[Abstract]
[PDF]
|
|
|
Ifosfamide is an active drug in Wilms' tumor: a phase II study conducted by the French Society of Pediatric Oncology |
| |
MF Tournade, J Lemerle, M Brunat-Mentigny, C Bachelot, H Roche, O Taboureau, D Olive, O Lejars, A Boilletot, and F Demeocq |
| |
JCO May 1 1988: 793–796.
[Abstract]
[PDF]
|
|
|
Effect of hydration on methotrexate plasma concentrations in children with acute lymphocytic leukemia |
| |
ML Christensen, GK Rivera, WR Crom, ML Hancock, and WE Evans |
| |
JCO May 1 1988: 797–801.
[Abstract]
[PDF]
|
|
|
Cellular pharmacokinetics of daunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia |
| |
E Kokenberg, P Sonneveld, W Sizoo, A Hagenbeek, and B Lowenberg |
| |
JCO May 1 1988: 802–812.
[Abstract]
[PDF]
|
|
|
Ovarian function following marrow transplantation for aplastic anemia or leukemia |
| |
JE Sanders, CD Buckner, D Amos, W Levy, FR Appelbaum, K Doney, R Storb, KM Sullivan, RP Witherspoon, and ED Thomas |
| |
JCO May 1 1988: 813–818.
[Abstract]
[PDF]
|
|
|
Stage IA to IIB mediastinal Hodgkin's disease: three-dimensional volumetric assessment of response to treatment |
| |
CG Willett, RM Linggood, JC Leong, LM Miketic, MA Stracher, SJ Skates, and DC Kushner |
| |
JCO May 1 1988: 819–824.
[Abstract]
[PDF]
|
|
|
Randomized clinical trial of tamoxifen alone or combined with fluoxymesterone in postmenopausal women with metastatic breast cancer |
| |
JN Ingle, DI Twito, DJ Schaid, SA Cullinan, JE Krook, JA Mailliard, RF Marschke, HJ Long, JG Gerstner, and HE Windschitl |
| |
JCO May 1 1988: 825–831.
[Abstract]
[PDF]
|
|
|
Adjuvant chemotherapy following surgical resection for small-cell carcinoma of the lung |
| |
FA Shepherd, WK Evans, R Feld, V Young, GA Patterson, R Ginsberg, and E Johansen |
| |
JCO May 1 1988: 832–838.
[Abstract]
[PDF]
|
|
|
Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study |
| |
SL Topalian, D Solomon, FP Avis, AE Chang, DL Freerksen, WM Linehan, MT Lotze, CN Robertson, CA Seipp, and P Simon |
| |
JCO May 1 1988: 839–853.
[Abstract]
[PDF]
|
|
|
Treatment of the patient with stage M0 soft tissue sarcoma |
| |
HD Suit, HJ Mankin, WC Wood, MC Gebhardt, DC Harmon, A Rosenberg, JE Tepper, and D Rosenthal |
| |
JCO May 1 1988: 854–862.
[Abstract]
[PDF]
|
|
|
Radiation therapy for acquired immunodeficiency syndrome-related Kaposi's sarcoma |
| |
LY Chak, PS Gill, AM Levine, PR Meyer, JA Anselmo, and Z Petrovich |
| |
JCO May 1 1988: 863–867.
[Abstract]
[PDF]
|
|
|
Assessing the effect of toxicity on prognosis: methods of analysis and interpretation |
| |
KJ Propert and JR Anderson |
| |
JCO May 1 1988: 868–870.
[Abstract]
[PDF]
|
|
|
Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme |
| |
TJ Kinsella, J Collins, J Rowland, R Klecker, Jr, D Wright, D Katz, SM Steinberg, and E Glastein |
| |
JCO May 1 1988: 871–879.
[Abstract]
[PDF]
|
|
|
Clinical modulation of doxorubicin resistance by the calmodulin- inhibitor, trifluoperazine: a phase I/II trial |
| |
RL Miller, RM Bukowski, GT Budd, J Purvis, JK Weick, K Shepard, KK Midha, and R Ganapathi |
| |
JCO May 1 1988: 880–888.
[Abstract]
[PDF]
|
|
|
Management of refractory myeloma: a review |
| |
AC Buzaid and BG Durie |
| |
JCO May 1 1988: 889–905.
[Abstract]
[PDF]
|
|
|
N-methylformamide: cytotoxic, radiosensitizer, or chemosensitizer |
| |
K Clagett-Carr, G Sarosy, J Plowman, DF Hoth, and B Leyland-Jones |
| |
JCO May 1 1988: 906–918.
[Abstract]
[PDF]
|
|
|
Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation |
| |
JD Rowley |
| |
JCO May 1 1988: 919–925.
[Abstract]
[PDF]
|
|
| High-dose cisplatin in elderly patients |
| U Tirelli |
|
JCO May 1 1988: 926a.
[PDF]
|
|
| Carcinoma of the cervix: chemotherapy, toxicity, and survival |
| GE Umbach |
|
JCO May 1 1988: 926b–927.
[PDF]
|
|
